SCHEMBL7477014

SCHEMBL7477014

CCCC(CCC)Nc1nc(C)nc(OS(=O)(=O)c2ccc(C)cc2)c1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
CA2 P00918 2/20 0.35
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
CRHR1 P34998 4/20 0.34
KCNH2 Q12809 2/20 0.32
HSP90AA1 P07900 2/20 0.32
CRHBP P24387 2/20 0.32
CRHR2 Q13324 2/20 0.32
ALDH1A1 P00352 4/20 0.32
MAPT P10636 3/20 0.32
LMNA P02545 2/20 0.32
GPR17 Q13304 1/20 0.32
KDM4E B2RXH2 1/20 0.32
PKM P14618 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CA1 P00915 1/20 0.31
CA7 P43166 1/20 0.31
CA13 Q8N1Q1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7484135 0.80 KEAP1 (0.51) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL17585445 0.77 MAPT (0.46) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL7628563 0.73 KEAP1 (0.40) KEAP1NFE2L2CRHR1ALDH1A1MAPT
SCHEMBL2492570 0.69 LMNA (0.44) KEAP1NFE2L2CA2CA12CA9
SCHEMBL6295022 0.68 POLB (0.34) CRHR1
SCHEMBL6432632 0.67 ALDH1A1 (0.38) CRHR1ALDH1A1MAPTLMNAKDM4E
SCHEMBL4322696 0.64 KEAP1 (0.53) KEAP1NFE2L2HSP90AA1CRHBPCRHR2
SCHEMBL7410681 0.64 KEAP1 (0.41) KEAP1NFE2L2ALDH1A1MAPTLMNA
SCHEMBL25461788 0.62 CA2 (0.53) CA2CA12CA9ALDH1A1CA1
SCHEMBL3634964 0.62 CA2 (0.53) CA2CA12CA9ALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448261-B1 CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC AND NEUROLOGICAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-10 US disclosed
EP-0935601-A4 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARM CO (US) 2002-08-07 EP disclosed
US-6107300-A CORTICOTROPIN RELEASING FACTOR ANTAGONIST; PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS (US) 2000-08-22 US disclosed
EP-0935601-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES Du Pont Pharmaceuticals Company (US) 1999-08-18 EP disclosed
WO-1997035539-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARMACEUTICALS COMPANY (US) 1997-10-02 WO disclosed